Tower Research Capital (TRC)’s Horizon Kinetics Medical ETF MEDX Stock Holding History

Tower Research Capital (TRC)’s Portfolio MEDX Stock Details MEDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1	Closed	-$26	–	5555
2024 Q4	$26	Buy	+1	New	+$29	﹤0.01%	5584

Other funds holding MEDX

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HWM

HighMark Wealth Management St. Paul, Minnesota $246M AUM 35.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Tower Research Capital (TRC)'s MEDX Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Horizon Kinetics Medical ETF (MEDX) in Q1 2025, closing a stake of 1 share — an estimated $26 sold.

Tower Research Capital (TRC) first reported a position in MEDX in Q4 2024 and held it in 1 quarter. The position peaked at $26 in Q4 2024. 4 funds tracked by Wall St. Rank hold MEDX as of Q1 2025.

Tower Research Capital (TRC) reported no remaining Horizon Kinetics Medical ETF position as of Q1 2025 after selling out during the quarter.
Tower Research Capital (TRC) sold 1 Horizon Kinetics Medical ETF share in Q1 2025, an estimated $26.
Tower Research Capital (TRC) first reported a position in Horizon Kinetics Medical ETF in Q4 2024 and held it in 1 quarter.
Tower Research Capital (TRC)'s Horizon Kinetics Medical ETF position peaked at $26 in Q4 2024.
4 funds tracked by Wall St. Rank held Horizon Kinetics Medical ETF as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.